Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?

Overview of attention for article published in Frontiers in Pharmacology, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 1 news outlet
twitter: 11 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 31 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

The GPCR Consortium, 11 Jun 2022

Good review! https://www.frontiersin.org/articles/10.3389/fphar.2022.893422/full

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.